抗体扩大了 ангиотензин受体的作用范围 药理学 药理学
Meredith A Skiba1, Sarah M Sterling1, Shaun Rawson1
1Department of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
bioRxiv : the preprint server for biology
|September 4, 2023
概括
研究人员开发了纳米体,一种抗体片段,作为血管新生素II型I受体 (AT1R) 的选择性对抗剂. 这些纳米体为G蛋白结合受体 (GPCRs) 提供了更好的选择性和可调的药理学.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 蛋白质工程是指蛋白质工程.
背景情况:
- G蛋白结合受体 (GPCRs) 对人类生理学至关重要,是药物的主要点.
- 目前的小分子配体在受体,组织和细胞水平上往往缺乏足够的选择性.
- 抗体显示出克服选择性限制的希望,但它们的GPCR配体特性尚未得到充分理解.
结论:
- 抗体碎片,像纳米体一样,可以作为有效和选择性的GPCR调节器.
- 纳米体为开发下一代GPCR向疗法提供了一个有前途的平台,具有增强的选择性.
- 这项研究强调了蛋白质工程在为复杂的生物标创造新药学工具方面的潜力.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
778
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
778
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
689
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
689
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Antihypertensive Drugs: Direct Renin Inhibitors
679
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
679
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Antihypertensive Drugs: Action of β1 Blockers
477
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
477


